Novartis (NVS)/ GlaxoSmithKline (GSK) Deal Makes Strategic Sense, Says Analyst
Go back to Novartis (NVS)/ GlaxoSmithKline (GSK) Deal Makes Strategic Sense, Says Analyst| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.96 | 52 Week High | $45.58 | |||
| Open | $51.96 | 52 Week Low | $37.82 | |||
| Day High | $51.96 | P/E | N/A | |||
| Day Low | $51.96 | EPS | $0.00 | |||
| Volume | 33,200 | |||||
| NOVARTIS AG (NYSE: NVS) | Delayed: 156.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $156.24 | 52 Week High | $89.15 | |||
| Open | $156.24 | 52 Week Low | $69.84 | |||
| Day High | $156.24 | P/E | N/A | |||
| Day Low | $156.24 | EPS | $0.00 | |||
| Volume | 926 | |||||
